Practical route to a new class of LTD4 receptor antagonists

Journal of Organic Chemistry

Volumn 61, Issue 10, 1996, Pages 3398-3405

  Larsen, Robert D ^a   Corley, Edward G ^a   King, Anthony O ^a   Carroll, James D ^a   Davis, Paul ^a   Verhoeven, Thomas R ^a   Reider, Paul J ^a   Labelle, Marc ^a   Gauthier, Jacques Y ^a   Xiang, Yi Bin ^a   Zamboni, Robert J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

L 691698; L 699392; LEUKOTRIENE D4 RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; REACTION ANALYSIS; STEREOCHEMISTRY; TECHNIQUE;

EID: 15844376844     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo952103j     Document Type: Article

References (48)

1. (a) Young, R. N.; Guindon, T. R.; Jones, T. R.; Ford-Hutchinson, A. W.; Bellanger, P.; Champion, E.; Charette, L.; DeHaven, R. N.; Denis, D.; Fortin, R.; Frenette, R.; Gauthier, J.-Y.; Gillard, J. W.; Kakushima, M.; Letts, L. G.; Masson, P.; Maycock, A.; McFarlane, C.; Piechuta, H.; Pong, S. S.; Rosenthal, A.; Williams, H.; Zamboni, R.; Yoakim, C.; Rokach, J. Advances in Prostaglandin, Thromboxane, And Leukotreine Research; Raven Press: New York, 1986; Vol. 16, p 37.
2. (b) Jones, T. R.; Zamboni, R.; Belley, M.; Champion, E.; Charette, L.; Ford-Hutchinson, A. W.; Frenette, R.; Gauthier, J.-Y.; Leger, S.; Masson, P.; McFarlane, C. S.; Piechuta, H.; Rokach, J.; Williams, H.; Young, R. N.; DeHaven, R N.; Pong, S. S. Can. J. Physiol. Pharmacol. 1989, 67, 17.
3. (c) Shaw, A.; Krell, R. D. J. Med. Chem. 1991, 34, 1235.
4. (d) Musser, J. H.; Kreft, A. F. J. Med. Chem. 1992, 35, 2501 and references cited therein.
5. (a) Gauthier, J. Y.; Jones, T.; Champion, E ; Charette, L.; Dehaven, R.; Ford-Hutchinson, A. W.; Hoogsteen, K.; Lord, A.; Masson, P.; Piechuta, H.; Pong, S. S.; Springer, J. P ; Therien, M.; Zamboni, R.; Young, R. N. J. Med. Chem. 1990, 33, 2841.
6. (b) Zamboni, R.; Belley, M.; Champion, E.; Charette, L.; DeHaven, R.; Frenette, R.; Gauthier, J. Y.; Jones, T. R.; Leger, S.; Masson, P.; McFarlane, C. S.; Metters, K.; Pong, S. S.; Piechuta, H.; Rockach, J.; Therien, M.; Williams, H. W. R.; Young, R. N. J. Med. Chem. 1992, 35, 3832.
7. McNamara, J. M.; Leazer, J. L.; Bhupathy, M.; Amato, J. S.; Reamer, R. A.; Reider, P. J.; Grabowski, E. J. J. J. Org. Chem. 1989, 54, 3718. For the preparation of the chiral derivative (MK-0679) by lipase-catalyzed asymmetric hydrolysis, see: Hughes, D. L.; Bergan, J. J., Amato, J. S.; Bhupathy, M.; Leazer, J. L.; McNamara, J. M.; Sidler, D. R.; Reider, P. J.; Grabowski, E. J. J. J. Org Chem. 1990, 55, 6252.
8. McNamara, J. M.; Leazer, J. L.; Bhupathy, M.; Amato, J. S.; Reamer, R. A.; Reider, P. J.; Grabowski, E. J. J. J. Org. Chem. 1989, 54, 3718. For the preparation of the chiral derivative (MK-0679) by lipase-catalyzed asymmetric hydrolysis, see: Hughes, D. L.; Bergan, J. J., Amato, J. S.; Bhupathy, M.; Leazer, J. L.; McNamara, J. M.; Sidler, D. R.; Reider, P. J.; Grabowski, E. J. J. J. Org Chem. 1990, 55, 6252.
9. (a) Labelle, M.; Prassit, P.; Belley, M.; Blouin, M.; Champion, E.; Charette, L.; DeLuca, J. G.; Dufresne, C.; Frenette, R.; Gauthier, J. Y.; Grimm, E.; Grossman, S. J.; Guay, D.; Herold, E. G.; Jones, T. R.; Lau, C. K.; Leblanc, Y.; Leger, S.; Lord, A.; McAuliffe, M.; McFarlane, C.; Masson, P.; Metters, K. M.; Ouimet, N.; Patrick, D. H.; Perrier, H.; Pickett, C. B.; Piechuta, H.; Roy, P.; Williams, H.; Wang, Z.; Xiang, Y. B.; Zamboni, R. J.; Ford-Hutchinson, A. W.; Young, R. N. Bioorg. Med. Chem. Lett. 1992, 2, 1141.
10. (b) Labelle, M.; Belley, M.; Champion, E.; Gordon, R.; Hoogsten, K.; Jones, T. R.; Leblanc, Y.; Lord, A.; McAuliffe, M.; McFarlane, C.; Masson, P.; Metters, K. M.; Nicoll-Griffith, D.; Ouimet, N.; Piechuta, H.; Rochette, C.; Sawyer, N.; Xiang, Y. B.; Yergey, J.; Ford-Hutchinson, A. W.; Pickett, C. B.; Zamboni, R. J.; Young, R. N. Bioorg. Med. Chem. Lett. 1994, 4, 463.
11. (c) Labelle, M.; Belley, M.; Gareau, Y.; Gauthier, J. Y.; Guay, D.; Gordon, R.; Grossman, S. G.; Jones, T. R.; Leblanc, Y.; McAuliffe, M.; McFarlane, C.; Masson, P.; Metters, K. M.; Ouimet, N.; Patrick, D. H.; Piechuta, H.; Rochette, C.; Sawyer, N.; Xiang, Y. B.; Pickett, C. B.; Ford-Hutchinson, A. W.; Zamboni, R. J.; Young, R. N. Bioorg. Med. Chem. Lett. 1995, 5, 283.
12. For an efficient approach to the ethenyl-bridged derivatives, see: King, A. O.; Corley, E. G.; Anderson, R. K.; Larsen, R D.; Verhoeven, T. R.; Reider, P. J.; Xiang, Y. B.; Eelley, M.; Leblanc, Y.; Labelle, M.; Prasit, P.; Zamboni, R. J. J. Org. Chum. 1993, 58, 3731.
13. (a) Baldwin, J. E.; Thomas, R. C.; Kruse, L. I.; Silberman, L. J. Org. Chem. 1977, 42, 3846.
14. (b) Bousquet, E. W.; Moran, M. D.; Harmon, J.; Johnson, A. L.; Summers, J. C. J. Org. Chem. 1975, 40, 2208 and references cited therein.
15. (c) Wattanasin, S.; Murphy, W. S. Synthesis 1980, 647.
16. (a) Biniecki, S.; Rylski, L. Ann. Pharm. Fr. 1958, 16, 21.
17. (b) A shorter approach could be the selective reduction of chlorophthalic anhydride; no success was obtained with this procedure. For an example of this method see: Taub, D.; Girotra, N. N.; Hoffsommer, R. D.; Kuo, C H.; Slates, H. L.; Weber, S.; Wendler, N. L. Tetrahedron 1968, 24, 2443.
18. Snieckus, V. Chem. Rev. 1990, 90, 879.
19. (a) Beak, P.; Brown, R. A. J. Org. Chem. 1977, 42, 1823.
20. (b) Beak, P.; Brown, R. A. J. Org. Chem. 1979, 44, 4463.
21. (c) Beak, P.; Brown, R. A. J. Org. Chem. 1982, 47, 34.
22. (d) Mills, R. J.; Snieckus, V. Tetrahedron Lett. 1984, 25, 483.
23. (e) Zani, C. L.; de Oliveira, A. B.; Snieckus, V. Tetrahedron Lett. 1987, 28, 6561.
24. (f) Harvey, R. G ; Cortez, C. J. Org. Chem. 1987, 52, 283.
25. (g) Kaino, M.; Ishihara, K.; Yamamoto, H. Bull. Chem. Soc. Jpn. 1989, 62, 3736.
26. Trost, B. M.; Rivers, G. T.; Gold, J. M. J. Org. Chem. 1980, 45, 1835.
27. (a) Comins, D. L.; Brown, J. D. Tetrahedron Lett. 1981, 22, 4213.
28. (b) Comins, D. L.; Brown, J. D.; Mantlo, N. B. Tetrahedron Lett. 1982, 23, 3979.
29. (c) Comins, D. L.; Brown, J. D. J. Org. Chem. 1984, 49, 1078.
30. (d) Comins, D. L.; Killpack, M. O. J. Org. Chem. 1987, 52, 104.
31. (e) Comins, D. L.; Brown, J. D. J. Org. Chem. 1989, 54, 3730.
32. (f) Tamao, K.; Yao, H.; Tsutsumi, Y.; Abe, H.; Hayashi, T.; Ito, Y. Tetrahedron Lett. 1990, 31, 2925.
33. (g) Comins, D. L. Synthesis Lett. 1992, 615.
34. Directed ortho metalation of the cyclohexylimine of 4-chlorobenzaldehdye only provided BuLi attack at the imine and no detectable ortho lithiation. Ortho lithiation of the cyclohexylimines is reported to work only with aryl groups with electron-donating groups present; see: Ziegler, F. E.; Fowler, K. W. J. Org. Chem. 1976, 41, 1564. For a list of other benzaldehyde-related ortho directing groups see ref 8.
35. Since the dimethylamide was ultimately desired, the metalation-carboxylation of 4-chlorobenzaldehyde was carried out with dimethylcarbamoyl chloride. The dimethylcarbamide derivative was obtained cleanly; however, upon subjecting the material to the coupling reaction the amide was easily hydrolyzed in situ to provide only 7b. (Equation Presented)
36. (a) Ojima, I.; Kogure, T. Organometallics 1982, 1, 1390.
37. (b) Nakamura, K.; Fujii, M.; Ohno, A.; Oka, S. Chem. Lett. 1984, 925.
38. (c) Malek, J. Org React. 1985, 34, 1.
39. (a) Corey, E. J ; Bakshi, R. K.; Shibata, S. J. Am. Chem. Soc. 1987, 109, 5551.
40. (b) Corey, E. J.; Bakshi, R. K.; Shibata, S.; Chen, C.-P.; Singh, V. K. J. Am Chem. Soc. 1987, 109, 7925.
41. (c) Corey, E. J.; Shibata, S.; Bakshi, R. K. J. Org. Chem. 1988, 53, 2861.
42. (d) Mathre, D. J.; Jones, T. K.; Xavier, L. C.; Blacklock, T. J.; Reamer, R. A.; Mohan, J. J.; Turner Jones, E. T.; Hoogsteen, K.; Baum, M. W.; Grabowski, E. J. J. J. Org. Chem. 1991, 56, 751.
43. (e) Mathre, D. J.; Thompson, A. S.; Douglas, A. W.; Hoogsten, K.; Carroll, J. D.; Corley, E. G.; Grabowski, E. J. J. J. Org. Chem. 1993, 58, 2880. (f) For the application of B-chlorodiisopinocampheylborane to these systems see ref 5.
44. The alkylation of the hydroxy ester 3b gave the crystalline product i. However, a major byproduct in the alkylation was the lactone ii (38%) formed by intramolecular esterification. Although the mixture of i and ii could be converted to 13, purification and isolation of the reaction intermediate was compromised. (Equation Presented)
45. For the preparation of the ethene bridge via the Wittig olefination, see: Lau, C. K.; Dufresne, C.; Gareau, Y ; Zamboni, R.; Labelle, M.; Young, R. N ; Metters, K. M.; Rochette, C.; Sawyer, N.; Slipetz, D. M.; Charette, L.; Jones, T.; McAuliffe, M.; McFarlane, C.; Ford-Hutchinson, A. W. Bioorg. Med. Chem. Lett. 1995, 5, 1615.
46. (a) Heck, R. G. Palladium Reagents in Organic Syntheses; Academic Press: San Diego, 1985.
47. (b) Heck, R. F. Vinyl Substitutions with Organopalladium Intermediates. In Comprehensive Organic Synthesis; Trost, B. M., Ed.; Pergamon Press: New York, 1991; Vol. 4, Chapter 3, p 833. (c) References cited in ref 5.
48. Kagan, E. S.; Ardashev, B. I. Chem Abstr. 1968, 68, 114408.